Bazelet Oglesby Introduces Cannabis America, a 0.00% THC Cannabis Plant

ORLANDO, Fla.–(BUSINESS WIRE)–Bazelet Oglesby [Bazelet] announces its new (cannabis) plant variety: Cannabis America, 100% genetically free of the psychoactive and illegal compound Δ9-Tetrahydrocannabinol [THC]. Bazelet’s Cannabis America plants are 100% THC-Free plants scientifically different from marijuana and all current hemp strains. The new Cannabis America plant is not just a unique variety of hemp but…

PerkinElmer Launches DA 7350™ Instrument and Cloud-Based Software for Quality Control in Food Production

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today introduced the DA 7350™ instrument and Process Plus™ cloud-based software to provide continuous quality control for food and food ingredient manufacturing processes. The new solution is designed to enable food producers to increase efficiency and yield and improve margins by…

Anthem More Than Doubled the Members Receiving Whole-person Treatment for Opioid Use Disorder

INDIANAPOLIS–(BUSINESS WIRE)–Anthem Blue Cross and Blue Shield more than the doubled the number of members in Medicaid, individual and employer-sponsored plans receiving whole-person therapies believed to produce better outcomes for opioid use disorder. To make a positive impact on member health and lessen the impact of the opioid epidemic, Anthem pledged four years ago to…

Dalwhinnie Farms Announces Grand Opening of Aspen Storefront, Reimagining the Traditional Cannabis Dispensary

ASPEN, Colo.–(BUSINESS WIRE)–Purveyor of fine Colorado cannabis, Dalwhinnie Farms, announced today the grand opening of its luxurious Aspen flagship boutique—providing an upscale shopping experience unlike any other. Dalwhinnie Farms reconceives the standard dispensary model as an immersive, upscale experience, aiming to reignite the joy of shopping for cannabis as customers are encouraged to browse a…

Traditional Medicinals Introduces New Line of Hemp+Herb Bagged Teas

SEBASTOPOL, Calif.–(BUSINESS WIRE)–Traditional Medicinals, pioneer of the wellness tea category in the U.S., today introduces Hemp+Herb bagged teas into its apothecary of herbal teas. The Hemp+Herb line consists of three teas specially formulated to support mental focus, stress relief, and joint health. With taste and efficacy in mind, each formula is supported by a combination…

VerdePharmHealth and Altopa Enter into Exclusive Partnership Agreement for Patient-Centric CBD Formulations

NEW HOPE, Pa.–(BUSINESS WIRE)–VerdePharmHealth today announced the signing of an exclusive national group purchasing agreement with Altopa, creator of the Oblend™, a patented device and technology platform that is able to create personalized, consistent products that leverage the new science around custom blended terpenes that are essential to maximizing patient outcomes. With the Oblend platform,…

Bluma Wellness Inc. Receives Approval for ‘One Plant Florida’ Tallahassee Dispensary and Delivery Hub Location, Announces Grant of RSUs

TORONTO–(BUSINESS WIRE)–Bluma Wellness Inc. (the “Company” or “Bluma Wellness”) (CSE: BWEL.U) is pleased to announce that its wholly-owned operating subsidiary, One Plant Florida, has received approval from the city of Tallahassee for its planned retail dispensary location in Tallhassee, Florida. The Company intends to open One Plant Florida’s Tallahassee retail dispensary location at or around…

EVIO Inc. Provides Shareholder Update

HENDERSON, Nev.–(BUSINESS WIRE)–EVIO Inc. (the “Company” or “EVIO”) (OTC:EVIO) is pleased to release the following Shareholder’s Letter. Dear Shareholders, In light of recent world events, EVIO continues to strive towards operating successfully in this new economy. Fortunately, the actions management took last year reducing operating costs, helped the company survive during the difficult months when…

Biotech Company Pascal Biosciences and SōRSE Technology Announce Partnership for Cannabinoid Drug Development and Cancer Clinical Trials

SEATTLE & VANCOUVER, British Columbia–(BUSINESS WIRE)–Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal”) and SōRSE Technology Corporation (“SōRSE”) have entered into a Collaborative Research Agreement to advance Pascal’s PAS-393 into clinical testing. Pascal and SōRSE will share their respective technologies to test the cannabinoid PAS-393 in human volunteers, enabling testing of cancer patients treated with checkpoint inhibitors. As…